Surgery Partners, Inc. (SGRY)
NASDAQ: SGRY · Real-Time Price · USD
14.11
+0.03 (0.21%)
Mar 5, 2026, 4:00 PM EST - Market closed
Surgery Partners Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$23.44
Upside
+66.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $28 → $20 | Strong Buy | Maintains | $28 → $20 | +41.74% | Mar 5, 2026 |
| UBS | UBS | Strong Buy Maintains $29 → $21 | Strong Buy | Maintains | $29 → $21 | +48.83% | Mar 5, 2026 |
| Mizuho | Mizuho | Buy Maintains $19 → $17 | Buy | Maintains | $19 → $17 | +20.48% | Mar 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $31 → $20 | Buy | Maintains | $31 → $20 | +41.74% | Mar 4, 2026 |
| Barclays | Barclays | Hold Maintains $18 → $14 | Hold | Maintains | $18 → $14 | -0.78% | Mar 3, 2026 |
| Mizuho | Mizuho | Buy Maintains $22 → $19 | Buy | Maintains | $22 → $19 | +34.66% | Dec 18, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $27 → $20 | Hold | Maintains | $27 → $20 | +41.74% | Nov 24, 2025 |
| Barclays | Barclays | Hold Maintains $24 → $18 | Hold | Maintains | $24 → $18 | +27.57% | Nov 21, 2025 |
| Mizuho | Mizuho | Buy Maintains $28 → $22 | Buy | Maintains | $28 → $22 | +55.92% | Nov 17, 2025 |
| UBS | UBS | Strong Buy Maintains $34 → $29 | Strong Buy | Maintains | $34 → $29 | +105.53% | Nov 13, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $31 | Buy | Maintains | $35 → $31 | +119.70% | Nov 11, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $35 → $30 | Strong Buy | Maintains | $35 → $30 | +112.62% | Nov 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $36 | Buy | Reiterates | $36 | +155.14% | Oct 7, 2025 |
| JP Morgan | JP Morgan | Hold Initiates $27 | Hold | Initiates | $27 | +91.35% | Sep 18, 2025 |
| Barclays | Barclays | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | +70.09% | May 27, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +148.05% | Apr 21, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.